misoprostol has been researched along with Coronary-Vasospasm* in 3 studies
3 other study(ies) available for misoprostol and Coronary-Vasospasm
| Article | Year |
|---|---|
Coronary artery vasospasm after misoprostol treatment for incomplete abortion: a case report.
Misoprostol is widely used for the medical management of incomplete abortion. Few serious adverse events have been reported, so it is considered a safe drug. We present a case of a 40-year-old woman in which misoprostol preceded coronary artery spasm. Topics: Abortifacient Agents, Nonsteroidal; Adult; Coronary Angiography; Coronary Vasospasm; Humans; Misoprostol | 2019 |
[Cardiac arrest induced by vasospastic angina pectoris after vaginally administered misoprostol].
A 41-year-old woman developed cardiac arrest after administration of misoprostol in order to induce an abortion. She was successfully resuscitated. Coronary angiography revealed coronary artery spasm which responded to nitroglycerine. Misoprostol is first-line treatment for medically induced abortion. Reports have described cardiovascular adverse events in women with cardiovascular risk factors, and clinicians should be aware of this. Topics: Abortion, Induced; Adult; Angina Pectoris; Coronary Vasospasm; Electrocardiography; Female; Heart Arrest; Humans; Misoprostol; Pregnancy | 2017 |
Acute coronary artery vasospasm associated with misoprostol for termination of pregnancy.
Prostaglandin E(1) analogues, gemeprost and misoprostol, are the most widely used drugs for medical termination of pregnancy within the first two trimesters of pregnancy. Gemeprost has been reported to be associated with acute cardiovascular accidents in a few cases, but no adverse cardiovascular events have been reported with misoprostol. For this reason, misoprostol has been considered a potentially safer drug and is widely recommended as a first-choice drug in combination with mifepristone. We report a case of a 32-year-old woman with active smoking and obesity, who developed an episode of transient acute coronary artery vasospasm following the administration of intravaginal misoprostol. This report illustrates that misoprostol can also be associated with acute coronary events, although it remains to be evaluated whether the risk is similar or lower to gemeprost. Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Analgesics; Chest Pain; Coronary Vasospasm; Coronary Vessels; Female; Humans; Ketoprofen; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Tromethamine | 2010 |